We are relentless in improving quality of life for those affected by cancer. With every action that we make, we are fulfilling the vision of the late Nicholas Colleluori, our founder. Nick’s last wish was that others would benefit from his journey. On behalf of all of us at HEADstrong, we invite you to join us.
“My name is Jessy Kyle and I am a three time survivor of Hodgkin’s Lymphoma. It was during my last battle that I met the HEADstrong family. I received a stem cell transplant in November of 2009 and was in the hospital on Thanksgiving Day. Annually, the HEADstrong Foundation™ provides Thanksgiving dinner for all of the oncology floors; feeding patients, their families, and staff at University of Pennsylvania. I have witnessed firsthand how HEADstrong’s hard work has truly benefited people battling cancer and I am proud to say that I have spent the last 3 Thanksgivings with HEADstrong at Penn serving meals to the community I belong to.”
Jessy Kyle
HEADstrong Survivor
“In September of 2014, our sweet 14 month old daughter was diagnosed with leukemia, completely devastating our family. Her health and diagnosis became complicated and we were forced to relocate to the Children’s Hospital of Philadelphia, over 2 hours away. We had the privilege of moving to Nick’s house and meeting the Colleluori family. They welcomed us with open arms. My daughter loved to run freely with all of her toys and it was so amazing to see her be a toddler again, and not one attached to an IV pole or living in a 12 x 12 hospital room in isolation! We appreciate everything that HEADstrong has provided my family. They gave us a warm, loving home where we could continue to make memories as a family even when faced with tough hardships.”
Emily Garibaldi
“HEADstrong Foundation™ has had a tremendous impact in research initiatives done on behalf of blood cancer patients at the Abramson Cancer Center through the Nicholas E. Colleluori Lymphoma Research Fund. The fund has provided support for duel-time point PET imaging as a means to diagnose a patient with either Hodgkin Lymphoma or B Cell Lymphoma. Through this trial and its findings, patients can receive a diagnosis without having to go through a biopsy. HEADstrong has made an appreciable impact on the lymphoma patients of the Abramson Cancer Center as well faculty and staff.”
Dr. Stephen Schuster
Director of the Lymphoma Program at Perelman Center for Advanced Medicine
D
O
N
A
T
E